Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 13, Issue 6
|
pp. 8026–8039
mTOR inhibition improves mitochondria function/biogenesis and delays cardiovascular aging in kidney transplant recipients with chronic graft dysfunction
Back to article
Figure 5
(5 of 7)
−
100%
+
Figure 5.
Serum levels of fluorescent hydroxynonenal- (HNE,
A
) and malondialdehyde- (MDA,
B
) protein adducts in patients treated with calcineurin inhibitor (CNi) or CNi + mTOR inhibitor (CNi+mTORi). AUF, arbitrary units of fluorescence.
